SCHEMBL9457337

SCHEMBL9457337

CCCCCC[C@@H](C(=O)O)C(O)CC(C)OC1CCCCO1

nearest known ligand 0.41

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 2/20 0.35
MEN1 O00255 1/20 0.35
GPR84 Q9NQS5 5/20 0.35
FFAR1 O14842 1/20 0.35
ALDH1A1 P00352 1/20 0.33
ACE2 Q9BYF1 1/20 0.33
MMP3 P08254 1/20 0.32
CTSK P43235 1/20 0.31
MAPT P10636 1/20 0.31
LCK P06239 1/20 0.31
PPARD Q03181 1/20 0.31
ZDHHC20 Q5W0Z9 1/20 0.31
ZDHHC2 Q9UIJ5 1/20 0.31
GRIK1 P39086 1/20 0.31
GRIK2 Q13002 1/20 0.31
NAAA Q02083 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9457405 1.00 KMT2A (0.35) KMT2AMEN1GPR84FFAR1ALDH1A1
SCHEMBL9457326 1.00 KMT2A (0.35) KMT2AMEN1GPR84FFAR1ALDH1A1
SCHEMBL9457121 1.00 KMT2A (0.35) KMT2AMEN1GPR84FFAR1ALDH1A1
SCHEMBL9457398 1.00 KMT2A (0.35) KMT2AMEN1GPR84FFAR1ALDH1A1
SCHEMBL9457330 1.00 KMT2A (0.35) KMT2AMEN1GPR84FFAR1ALDH1A1
SCHEMBL9457048 0.89 KMT2A (0.35) KMT2AMEN1GPR84FFAR1ALDH1A1
SCHEMBL9457037 0.89 KMT2A (0.35) KMT2AMEN1GPR84FFAR1ALDH1A1
SCHEMBL9457001 0.89 KMT2A (0.35) KMT2AMEN1GPR84FFAR1ALDH1A1
SCHEMBL9865919 0.89 KMT2A (0.35) KMT2AMEN1GPR84FFAR1ALDH1A1
SCHEMBL9457043 0.89 KMT2A (0.35) KMT2AMEN1GPR84FFAR1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5246960-A Used to treat obesity, hyperlipaemia, atherosclerosis and arteriosclerosis HOFFMANN-LA ROCHE INC. (US) 1993-09-21 US disclosed
US-5175186-A Inhibits pancreas lepase and useful agent in treatment of obesity, hyperlipemia, atherosclerosis and arteriosclerosis HOFFMANN-LA ROCHE INC. (US) 1992-12-29 US disclosed
US-4931463-A PANCREAS LIPASE INHIBITORS HOFFMANN-LA ROCHE INC. (US) 1990-06-05 US disclosed